Literature DB >> 8386612

Identical complementary deoxyribonucleic acids encode a human renal and bone parathyroid hormone (PTH)/PTH-related peptide receptor.

E Schipani1, H Karga, A C Karaplis, J T Potts, H M Kronenberg, G V Segre, A B Abou-Samra, H Jüppner.   

Abstract

Identical complementary DNAs (cDNAs) that encode a 593-amino acid human PTH (PTH)/PTH-related peptide (PTHrP) receptor were isolated by hybridization techniques from two cDNA libraries which had been constructed from human kidney and human osteoblast-like osteosarcoma cells (SaOS-2). Northern blot analysis of total RNA from human bone- and kidney-derived tissue revealed one single major messenger RNA species of about 2.5 kilobases in both tissues. The human PTH/PTHrP receptor has 91% and 81% identity, respectively, with the previously cloned rat and opossum receptors, indicating a high degree of conservation among mammals. Despite this striking degree of amino-acid conservation, the human PTH/PTHrP receptor has several unique biological properties when transiently expressed in COS-7 cells. The apparent dissociation constants for [Nle8,18,Tyr34] bovine PTH(1-34) amide [bPTH(1-34)] are similar for the human and the rat receptor (approximately 8 vs. approximately 15 nM) whereas [Tyr36]PTHrP(1-36) amide has a slightly lower affinity for the human (15-40 nM) than for the rat receptor (approximately 15 nM). Both ligands stimulate efficiently and with similar efficacy the accumulation of intracellular cAMP. The affinities for the antagonists [Nle8,18,Tyr34] bPTH(3.34) amide [bPTH(3-34)] and in particular for [Nle8,18,Tyr34] bPTH(7-34) amide [bPTH(7-34)] are considerably higher for the human receptor, e.g. approximately 8 nM vs. 30 nM for bPTH(3-34) and approximately 100 nM vs. 5000 nM for bPTH(7-34), respectively. Similar biological findings were previously attributed to differences in species- and/or organ-specific PTH/PTHrP receptors. The expression of the recombinant, highly homologous rat and human receptors in a uniform environment indicate that the moderate differences in the primary receptor structure have profound consequences for the receptor binding affinity of amino-terminally truncated PTH analogs. Furthermore, the molecular cloning of identical cDNAs encoding a human PTH/PTHrP receptor from the two major target organs for PTH, bone and kidney, provides strong evidence for one single PTH/PTHrP receptor in both organs, although additional and/or alternatively spliced receptors cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386612     DOI: 10.1210/endo.132.5.8386612

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  27 in total

Review 1.  Clinical spectrum and pathogenesis of pseudohypoparathyroidism.

Authors:  M A Levine
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 2.  The PTH/PTHrP receptor in Jansen's metaphyseal chondrodysplasia.

Authors:  L M Calvi; E Schipani
Journal:  J Endocrinol Invest       Date:  2000-09       Impact factor: 4.256

3.  Long-term culture in dexamethasone unmasks an abnormal phenotype in osteoblasts isolated from osteoporotic subjects.

Authors:  L G Rao; T M Murray; J N Wylie; R J McBroom; M Kung Sutherland
Journal:  J Endocrinol Invest       Date:  2005-11       Impact factor: 4.256

4.  Parathyroid hormone signaling via Gαs is selectively inhibited by an NH(2)-terminally truncated Gαs: implications for pseudohypoparathyroidism.

Authors:  Svetlana Puzhko; Cynthia Gates Goodyer; Mohammad Amin Kerachian; Lucie Canaff; Madhusmita Misra; Harald Jüppner; Murat Bastepe; Geoffrey N Hendy
Journal:  J Bone Miner Res       Date:  2011-10       Impact factor: 6.741

5.  Expression of parathyroid hormone receptors in MDCK and LLC-PK1 cells.

Authors:  G Hayes; J Forgo; F R Bringhurst; G Segre; H Murer
Journal:  Pflugers Arch       Date:  1995-09       Impact factor: 3.657

6.  Signaling by N- and C-terminal sequences of parathyroid hormone-related protein in hippocampal neurons.

Authors:  S Fukayama; A H Tashjian; J N Davis; J C Chisholm
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

7.  Developmental upregulation of human parathyroid hormone (PTH)/PTH-related peptide receptor gene expression from conserved and human-specific promoters.

Authors:  J D Bettoun; M Minagawa; G N Hendy; L C Alpert; C G Goodyer; D Goltzman; J H White
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

8.  Parathyroid hormone/parathyroid hormone related peptide receptor gene transcripts are expressed from tissue-specific and ubiquitous promoters.

Authors:  K A McCuaig; H S Lee; J C Clarke; H Assar; J Horsford; J H White
Journal:  Nucleic Acids Res       Date:  1995-06-11       Impact factor: 16.971

9.  Heparin-insensitive calcium release from intracellular stores triggered by the recombinant human parathyroid hormone receptor.

Authors:  K Seuwen; H G Boddeke
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

10.  Agonist-regulated cleavage of the extracellular domain of parathyroid hormone receptor type 1.

Authors:  Christoph Klenk; Stefan Schulz; Davide Calebiro; Martin J Lohse
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.